Skip to main content
. 2019 Sep 26;11(9):594–603. doi: 10.4252/wjsc.v11.i9.594

Figure 1.

Figure 1

The main pathways activated by different estrogen receptor isoforms in breast cancer stem cells, responsible for cell proliferation and tamoxifen-resistance. GPER: G-protein coupled receptor; ERα36: estrogen receptor alpha 36; ERβ: estrogen receptor beta; MEK: Mitogen activated protein kinase; ERK: extracellular signal-regulated kinase; YAP: Yes-associated protein; TAZ: Tafazzin.